Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ALLO
CRMD
Add up to 3 more stocks
ALLO
Allogene Therapeutics, Inc.
-3.07%
$1.45-0.05Delayed quote: Oct 6, 2026, 10:55 AM EDT
Market Cap
$501.86M
52W Range
$1.04 - $4.46
CRMD
CorMedix Inc.
-0.96%
$7.19-0.07Delayed quote: Oct 6, 2026, 10:55 AM EDT
Market Cap
$564.07M
52W Range
$6.13 - $13.02
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 3.38 |
| Forward P/E | N/A | 14.53 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.15 | 1.22 |
| P/S Ratio | 108.16 | 1.22 |
| P/FCF Ratio | N/A | 2.25 |
| EV/EBITDA | N/A | 1.79 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 82.8% |
| Operating Margin | 0.0% | 47.0% |
| Net Margin | -3566.7% | 40.5% |
| ROE | -37.9% | 40.6% |
| ROA | -30.1% | 20.7% |
| ROIC | -34.8% | 27.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 10.72 | 2.56 |
| Quick Ratio | 10.72 | 2.36 |
| Debt/Equity | 0.16 | 0.31 |
| Interest Coverage | -192.50 | 53.97 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.